tiprankstipranks
Arch Therapeutics (ARTH)
OTHER OTC:ARTH

Arch Therapeutics (ARTH) Technical Analysis

160 Followers

Summary of all the Indicators

Overall Consensus
Sell
7Bullish
5Neutral
10Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Arch Therapeutics’s (ARTH) Moving Averages Convergence Divergence (MACD) indicator is -0.07, suggesting Arch Therapeutics is a Sell.
Arch Therapeutics’s (ARTH) 20-Day exponential moving average is 0.97, while Arch Therapeutics’s (ARTH) share price is $0.99, making it a Sell.
Arch Therapeutics’s (ARTH) 50-Day exponential moving average is 1.17, while Arch Therapeutics’s (ARTH) share price is $0.99, making it a Sell.

Arch Therapeutics (ARTH) Pivot Points

Jul 05, 2024, 08:26 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.75
0.78
0.79
0.83
0.84
0.87
0.89
Fibonacci
0.78
0.80
0.81
0.83
0.84
0.85
0.87
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Arch Therapeutics (ARTH) Moving Averages

Jul 05, 2024, 08:26 PM
Period
Simple
Exponential
MA5
0.88Buy
0.90Buy
MA10
0.91Buy
0.92Buy
MA20
0.96Buy
0.97Sell
MA50
1.07Sell
1.17Sell
MA100
1.53Sell
1.62Sell
MA200
2.56Sell
2.08Sell
Arch Therapeutics’s (ARTH) 10-Day exponential moving average is 0.92, while Arch Therapeutics’s (ARTH) share price is $0.99, making it a Buy.
Arch Therapeutics’s (ARTH) 100-Day exponential moving average is 1.62, while Arch Therapeutics’s (ARTH) share price is $0.99, making it a Sell.
Arch Therapeutics’s (ARTH) stock price is $0.99 and Arch Therapeutics’s (ARTH) 50-day simple moving average is 1.07, creating a Sell signal.
Arch Therapeutics’s (ARTH) stock price is $0.99 and Arch Therapeutics’s (ARTH) 100-day simple moving average is 1.53, creating a Sell signal.
Arch Therapeutics’s (ARTH) stock price is $0.99 and Arch Therapeutics’s (ARTH) 200-day simple moving average is 2.56, creating a Sell signal.

Arch Therapeutics (ARTH) Technical Indicators

Jul 05, 2024, 08:26 PM
Name
Value
Implied Action
RSI (14)
47.89
Neutral
STOCH (9,6)
32.34
Neutral
STOCHRSI (14)
30.04
Neutral
MACD (12,26)
-0.07
Sell
ADX (14)
16.71
Buy
Williams %R
-47.37
Buy
CCI (14)
-23.95
Neutral
ATR (14)
0.10
-
Ultimate Oscillator
58.59
Neutral
ROC
-1.03
Sell
Arch Therapeutics’s (ARTH) Relative Strength Index (RSI) is 47.89, creating a Neutral signal.
Arch Therapeutics’s (ARTH) Trend Strength Indicator (ADX) is 16.71, creating a Buy signal.
Arch Therapeutics’s (ARTH) Commodity Channel Index (CCI) is -23.95, creating a Neutral signal.
Arch Therapeutics’s (ARTH) Price Rate of Change (ROC) is -1.03, creating a Sell signal.

FAQ

Is ARTH a Buy, Hold, or Sell?
Based on ARTH’s technical indicators, ARTH is a Sell.
    What is ARTH’s RSI (14)?
    ARTH’s RSI (14) is 47.89, which suggests ARTH is a Neutral.
      What is ARTH’s MACD?
      ARTH’s MACD is -0.07, which suggests ARTH is a Sell.
        What is ARTH’s 5-day moving average?
        ARTH’s 5-day moving average is 0.88, which suggests ARTH is a Buy.
          What is ARTH’s 20-day moving average?
          ARTH 20-day moving average is 0.96, which suggests ARTH is a Buy.
            What is ARTH’s 50-day moving average?
            ARTH’s 50-day moving average is 1.07, which suggests ARTH is a Sell.
              What is ARTH’s 200-day moving average?
              ARTH’s 200-day moving average is 2.56, which suggests ARTH is a Sell.
                What is ARTH’s Williams % R (14)?
                ARTH’s Williams % R (14) is -47.37, which suggests ARTH is a Buy.
                  What is ARTH’s CCI (14)?
                  ARTH’s CCI (14) is -23.95, which suggests ARTH is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis